Stock listing

Hemogenyx Pharmaceuticals Plc

Selected listing: HEMOL · TURQUOISE · GBX · GB

Hemogenyx Pharmaceuticals Plc (Turquoise:HEMOL), Health Technology. Latest release Sep 30, 2026: Total Voting Rights.

HEMOL:TURQUOISEGBXGBUpdated October 2, 2026

Ticker: Turquoise:HEMOL
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Turquoise
Currency: GBX

About Hemogenyx Pharmaceuticals Plc

The company focuses on developing innovative therapies for blood disorders and related conditions. Hemogenyx is dedicated to advancing its research and development efforts to bring new treatment options to patients.

Latest news from Hemogenyx Pharmaceuticals Plc

Total Voting Rights

September 30, 2026

Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report

September 28, 2026

Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies

August 11, 2026

Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update

July 29, 2026

Hemogenyx Pharmaceuticals PLC Announces Notice of AGM

June 5, 2026

All Hemogenyx Pharmaceuticals Plc news →

Research Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc company profile

View the public company page for Hemogenyx Pharmaceuticals Plc on 6ix.

Hemogenyx Pharmaceuticals Plc news

Read company news and market updates connected to Hemogenyx Pharmaceuticals Plc.

Hemogenyx Pharmaceuticals Plc investor events

Find investor webinars, events, and replay context for Hemogenyx Pharmaceuticals Plc.